^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Purinergic receptor P1 agonist

    Related drugs:
    Apply
    Therapy Optimisation for the Treatment of Hairy Cell Leukemia (NCT02131753)
    Phase 2/3
    University of Giessen
    Recruiting
    Last update posted :
    05/10/2023
    Initiation :
    05/01/2004
    Primary completion :
    12/01/2025
    Completion :
    12/01/2027
    CD19 • IL2RA • ITGAE • ISG20
    |
    cladribine
    GM-CLAG in Relapsed/Refractory FLT3-mutated AML (NCT05330377)
    Phase 1
    Ayman H Qasrawi
    Withdrawn
    Last update posted :
    04/25/2023
    Initiation :
    03/01/2023
    Primary completion :
    05/30/2027
    Completion :
    05/30/2032
    FLT3
    |
    FLT3-ITD mutation • FLT3-TKD mutation
    |
    cytarabine • Xospata (gilteritinib) • mitoxantrone • cladribine • Neupogen (filgrastim)